Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant ...
24/7 Wall St22 小时
NIO (NIO) Stock Price Prediction and Forecast 2025-2030 For February 13
The Chinese carmaker’s high-performance models, which feature a +600-mile range, have caught the eye of vehicle enthusiasts ...